Table 2.
Differences in the 1-year OSA treatment pathways by insurance provider (n=31,585)
Percentage of patients on each treatment pathway | Odds ratio for likelihood of each treatment pathway in Medicaid patients (ref: Commercial)+ | ||||
---|---|---|---|---|---|
All | Commercial | Medicaid | OR | 95% CI | |
(1) Surgical care + PSG | 11.4% | 11.3% | 11.7% | 1.02 | .95, 1.09 |
(2) Surgical care only | 31.8% | 30.6% | 32.9% | 1.21 | 1.15, 1.28 |
(3) PSG + specialty care | 5.9% | 8.0% | 4.5% | .52 | .47, 57 |
(4) PSG only | 6.4% | 5.0% | 7.3% | 1.46 | 1.32, 1.61 |
(5) Specialty care only | 6.1% | 8.1% | 4.7% | .57 | .52, .63 |
(6) PAP care | 3.4% | 4.0% | 3.1% | .68 | .59, .77 |
(7) No care | 34.4% | 33.0% | 35.8% | 1.13 | 1.07, 1.18 |
(8) Comprehensive care | 0.6% | -- | -- | -- | -- |
PAP=positive airway pressure; PSG=polysomnography.
Binomial logistic regression models after adjusting for child gender, age, any complex chronic conditions, and obesity during 1-year prior to and at time of OSA diagnosis. Bold indicates significant associations (p<0.05).
PSG + surgical care: Any PSG prior to, at the time of, or post-OSA diagnosis plus surgical care (adenotonsillectomy, tonsillectomy, adenoidectomy).
Surgical care only: Surgical care without any PSG history.
PSG + specialty care: Any PSG prior to, at the time of, or post-OSA diagnosis plus pulmonary and/or otolaryngology visits.
PSG only: Any PSG prior to, at the time of, or post-OSA diagnosis with no surgical care, no PAP, and no specialty care.
Specialty care only: Pulmonary and/or otolaryngology visits only with no PSG, no surgical care, and no PAP.
PAP care: PAP prescription and/or PSG with PAP titration.
No treatment: No PSG history, surgical care, specialty care, or PAP care.
Comprehensive care: Excluded due to small sample size (n=202) and high utilization of OSA-related care (i.e., surgical care, PAP, and/or PSG, and/or specialty care).